The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Omoto, Y.
Right arrow Articles by Mizutani, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Omoto, Y.
Right arrow Articles by Mizutani, H.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*Protein
*UniGene
*Substance via MeSH
The Journal of Immunology, 2006, 177: 8315-8319.
Copyright © 2006 by The American Association of Immunologists, Inc.

Human Mast Cell Chymase Cleaves Pro-IL-18 and Generates a Novel and Biologically Active IL-18 Fragment1

Youichi Omoto*,§, Kazuya Tokime*,§, Keiichi Yamanaka*,§, Koji Habe*, Tatsuhiko Morioka*, Ichiro Kurokawa*, Hiroko Tsutsui{dagger},§, Kiyofumi Yamanishi{ddagger},§, Kenji Nakanishi{dagger},§ and Hitoshi Mizutani2,*,§

* Department of Dermatology, Mie University, Graduate School of Medicine, Tsu, Mie, Japan; {dagger} Department of Immunology and Medical Zoology and {ddagger} Dermatology, Hyogo College of Medicine, Nishinomiya, Japan; and § Core Research of Evolutional Science and Technology, Japan Science and Technology Agency, Kawaguchi, Japan

Increased release of IL-18 in the skin causes atopic dermatitis (AD)-like skin lesions, suggesting a role of IL-18 in the pathogenesis of AD. Caspase-1 is a well-known activator of IL-18, but caspase-1 knockout mice still have biologically active IL-18. Normal human keratinocyte constitutively produces pro-IL-18, but it is unable to activate it, suggesting the existence of an alternative pathway for IL-18 in the skin. Dermal accumulation of mast cells is commonly observed in AD patients and in experimental mouse models of AD. Connective tissue mast cells contain high amounts of chymase and tryptase in their cytoplasmic granules. In the present study, we demonstrated that activation of IL-18 is a novel function of human mast cell chymase. Human mast cell chymase rapidly cleaves recombinant pro-IL-18 at 56-phenylalanine and produces a biologically active IL-18 fragment that is smaller than any other reported IL-18-derived species. The human mast cell chymase and the novel IL-18-derived active peptide may be novel therapeutic targets in AD- and IL-18-associated diseases

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported by Core Research of Evolutional Science and Technology, Japan Science and Technology Corp.

2 Address correspondence and reprint requests to Dr. Hitoshi Mizutani, Department of Dermatology, Mie University, Graduate School of Medicine, Tsu, Mie 514-8507, Japan. E-mail address: h-mizuta{at}clin.medic.mie-u.ac.jp

3 Abbreviations used in this paper: mat-IL-18, mature IL-18; AD, atopic dermatitis; pro-IL-18, precursor IL-18; rpro-IL-18, recombinant precursor IL-18; CBB, Coomassie brilliant blue.




This article has been cited by other articles:


Home page
Exp. Biol. Med.Home page
R. Yanagisawa, H. Takano, K.-i. Inoue, E. Koike, T. Kamachi, K. Sadakane, and T. Ichinose
Titanium Dioxide Nanoparticles Aggravate Atopic Dermatitis-Like Skin Lesions in NC/Nga Mice
Experimental Biology and Medicine, March 1, 2009; 234(3): 314 - 322.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.